LOXL2 and neoplasm: This post-translational modification of the receptor protein significantly increases its affinity for its ligand PDGF,[72] which is an important mitogen in the context of tumour progression.[81] A corresponding effect on the PDGF receptor of cancer-associated fibroblasts (CAFs) was also identified for LOXL2 secreted by tumour cells.[82]